Select Committee on Public Accounts Sixteenth Report


SIXTEENTH REPORT


The Committee of Public Accounts has agreed to the following Report:—

THE NATIONAL BLOOD SERVICE

INTRODUCTION AND SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS

1. The National Blood Authority—a special health authority of the NHS—runs the National Blood Service and is responsible for the collection and distribution of blood components in England and North Wales. The availability of blood is essential to the NHS, and many people owe their lives to transfusions that were made possible by voluntary donations of blood.


2. Since its creation in 1993, the National Blood Service has been reorganising from a regional to a national service, and aspects of this process led to some concerns among users and employees. In August 1997, the Secretary of State commissioned a review of the clinical concerns raised about the Service's proposals to transfer processing and testing of blood from Liverpool to Manchester. The report led to the dismissal of the Service's chairman and chief executive because of serious concerns about the way the Service had been managed. The National Blood Service completed its transition to a national organisation in April 2000.[1] We examined the performance of the Service, focussing on steps taken to improve donor care, the safety of blood used in transfusions, the use of blood and overall management and efficiency.

3. In the light of our examination, we draw three overall conclusions.

  • Since the major concerns about the management and organisation of the National Blood Service in the 1990s, the Service has made significant progress in moving towards a national organisation, meeting hospital demand, improving the safety of blood products and improving its efficiency. It has achieved this while having to cope with increased processing and costs of removing white cells from donated blood to reduce the risk of infection from variant Creutzfeldt Jakob disease.

  • Despite these improvements, there remains much to be done to improve donor care. Existing donors are stopping giving blood at the rate of 200,000 a year, and although over 400,000 new potential donors enrol each year, the Service has only managed to convert 60 per cent of them into donors. If the Service is to continue to meet demand for blood, there now needs to be a step change in the way it treats donors at every stage. This will involve new investment in information technology, wider adoption of good practice in some areas, and further changes in working practices;

  • Delays experienced by donors in giving blood are rising, and are the biggest cause of complaint about the Service's performance. While the Service recognises the challenge, and steps to improve blood safety have contributed to the delays, it is clear that the lack of effective information technology systems inhibits progress. It will be three years before the Service is able to offer all donors a modern appointments system linked to their national call centre, and thus minimise waiting times. We look to the Service to complete this work as quickly as possible.

4. Our more specific conclusions and recommendations are as follows:

On improving donor care

      (i)  Donors are the foundation of the National Blood Service. The Service needs to keep existing donors and expand the numbers, if it is to continue to meet demand. The Service is now taking steps to improve its contact with existing donors, and to convert those who express an interest in giving blood into donors (paragraph 13);

      (ii)  The Service has not undertaken a national survey of donors since 1989. While its targeted surveys may be useful, the full survey undertaken by the National Audit Office provided new insights and if repeated at least every 5 years would provide the Service both with a comprehensive record of current issues and independent evidence of progress. The Service should re-introduce periodic national surveys as part of its measures to track attitudes to donation, and donor satisfaction (paragraph 14);

On improving the safety of blood used in transfusions

      (iii)  Safety in blood products and their use is paramount. The number of deaths is thankfully very low, but any instances of cross infection or misuse of blood can have very serious consequences for patients, as evidenced by those people infected with HIV and with Hepatitis C. The Department and the National Blood Service should continue to develop their links with the research and scientific community and the manufacturing sector so that they are able to respond quickly to new developments, and minimise the risk of infection (paragraph 22);

On improving the use of blood

      (iv)  Unless the National Blood Service and hospitals make the best use of blood, there is a risk that there will be less willingness to donate. The Blood Stocks Management Scheme and the Better Blood Transfusion are useful initiatives in helping to minimise wastage, and we look to the National Blood Service to continue its efforts to ensure better management of blood (paragraph 26);

      (v)  Only the National Blood Service can take blood from donors, and there is no other source of supply of blood to non-NHS hospitals. Although there is no evidence that non-NHS hospitals have sought to make a profit on blood supplied, the Blood Service needs independent evidence of this. The Service should re-examine the contractual arrangements and consider whether additional assurance, perhaps in the form of audit certificates might improve its confidence, and that of donors, on this point (paragraph 27);

On improving the management and operations of the National Blood service

      (vi)  The conclusions of the Cash report, and the terms in which the Secretary of State announced the dismissal in 1997 of the Chairman and Chief Executive, were highly critical of the way the Service was managed. While we recognise the need for the Service to operate within the terms of contract and its disciplinary arrangements, we are astonished that the Chief Executive was able to leave with a payoff of £108,000 and a £124,000 contribution to his pension fund. This is not the first case where those responsible for poor management have received significant payoffs. The Department should review the NHS arrangements for taking disciplinary action in such cases (paragraph 38);

      (vii)  The National Blood Service has taken a number of steps to rebuild confidence following the crisis that developed in the 1990s. Four years on, however, it has still not concluded a deal with staff on new pay, conditions and working practices that will give donors the service they need. The Service should pursue negotiations vigorously (paragraph 39).

IMPROVING DONOR CARE

5. In 1998-99, the National Blood Service collected 2.4 million voluntary donations of blood from 1.9 million people, and in 1999-2000 met hospitals' demand for blood. However, the Comptroller and Auditor General noted there was a need to stem the loss of donors through bad experiences of giving blood, for example by reducing the time it takes to give blood, and potential for increasing the availability of donors.[2]

6. He reported that existing donors were stopping giving blood at the rate of around 200,000 a year. The National Blood Service had identified over 400,000 new potential donors in 1999-2000 but had only been successful in getting 60 per cent of those to give blood. At the same time, complaints from donors about the Service had increased from 4,846 in 1997-98 to 7,792 in 1999-2000, although the Service's performance in dealing with them within 20 working days had improved from 75 per cent to 80 per cent.[3]

7. The National Blood Service accepted that a number of the steps it had taken to improve blood safety had made the process more complicated and had slowed the service down. These included more safety checks and different operating procedures. The Service was now trying to speed it up again, without compromising safety. It was looking at session opening times and locations, and supplementing staff with more volunteers supporting the service, which in turn would recapture the local connection. But these initiatives would take time to work through, because the Service had to take staff with them and maintain safety all the time.[4]

8. The Comptroller and Auditor General noted some deterioration in the Service's performance in meeting waiting time targets, and that the most frequent cause of complaints was delays at donor sessions.[5] The Service confirmed that people should not have to wait. All its static clinics offered appointments. It had started to move industrial sessions, at employers' premises, on to appointments and would complete that next year. But in only 20 per cent of mobile public sessions were donors offered appointments. The Service was putting appointment systems in where they could be run reliably, but its current information technology systems were not robust. For example, they did not allow donors to change their appointments. The Service had inherited 11 different systems, which were incapable of communicating with each other, and had three donor databases. The Service had initially focussed its attention on improving those systems linked to blood safety. But it was now trying to create a single donor database and introduce a proper appointments system that would work with its national call centre. The Service hoped to be able to offer a significantly better service, and to have eliminated unacceptable waiting times, across the whole country in three years.[6]

9. Despite these steps, the Service still saw a need to continue to offer some drop-in sessions for those who did not want appointments. It also accepted the need to ensure consistency in the treatment of donors. This extended from the way donors were treated if they had to wait, to improvements in giving them the right information, for example the results of blood tests. Here too, the Service's systems were weak because they did not have a proper audit trail linking donors to test results. It expected to solve that particular problem in the next few months.[7]

10. As regards minimising the number of lapsed donors, the Service had just started to mail their Donor magazine to all active donors. With the Post Office, it was cleaning up wrong addresses on its databases. The Service was also advertising on television and radio, to keep up public awareness.[8]

11. For new donors, the Service recognised that stating an intention to give blood and actually giving blood were two separate stages. It was trying to improve the proportion of those who became donors, in a number of ways. For example, the Service was very much more active in going back to people and offering them appointments. It was improving invitation letters. And it had developed a video to send to newly enrolled donors. However, the Service did not consider that incentives would bring more donors forward, noting that the donor survey carried out by the National Audit Office had identified only one per cent of lapsed and non-donors who would be motivated by payment.[9]

12. The Service recognised the need to survey donors, to keep abreast of their concerns. Most of its own survey work was very targeted, and it had found the survey undertaken by the National Audit Office very useful. That survey had confirmed the Service's own findings, and added new insights. For example, donors had advised against emphasising the medical aspects of the service, in favour of the altruism in donation. As regards complaints, the Service felt that the increase in 1999-2000 had partly resulted from the success of television campaigns. These had increased the number of donors, leading to very significant waiting times at some sessions. The Service was trying to make the complaints system more responsive to donors, and was committed to improving the speed with which they responded.[10]

Conclusions

13. Donors are the foundation of the National Blood Service. The Service needs to keep existing donors and expand the numbers, if it is to continue to meet demand. The Service is now taking steps to improve its contact with existing donors, and to convert those who express an interest in giving blood into donors.

14. The Service has not undertaken a national survey of donors since 1989. While its targeted surveys may be useful, the full survey undertaken by the National Audit Office provided new insights and if repeated at least every 5 years would provide the Service both with a comprehensive record of current issues and independent evidence of progress. The Service should re-introduce periodic national surveys as part of its measures to track attitudes to donation, and donor satisfaction.

ENSURING THE SAFETY OF BLOOD USED IN TRANSFUSIONS

15. In 1999-2000, the National Blood Service supplied blood for around 800,000 transfusions. The number of verifiable deaths linked to unsafe blood components was very low, there were comprehensive arrangements for securing safety, and the Serious Hazards of Transfusion Steering Group had concluded in April 2000, that blood transfusion was now extremely safe. In particular, since 1998, leucodepletion—the removal of white cells to reduce the risk of infection from variant Creutzfeldt Jakob Disease—has been extended to all blood destined for transfusion.[11]

16. The Committee asked about the steps taken or planned by the Department of Health and the National Blood Service to reduce further the theoretical risk of transmission of variant Creutzfeldt Jakob Disease through transfusion. The Department assured us that all instruments used for taking blood were disposable. The Microbiological Safety of Blood and Tissues for Transplantation Committee were considering questions around the use of fresh frozen plasma, and planned to give the Department advice on 19 April.[12]

17. The National Blood Service told us that scientifically the risk of people receiving blood with variant Creutzfeldt Jakob Disease was unknown. The impact it was going to have on the Service's core processes was one of the biggest uncertainties it faced. The Service had taken all the measures Ministers and the Department had required, and was making sure it was as up to date as possible. However, the science was developing. Work was in hand to assess whether there were certain high-risk categories of people that might be screened, and whether there were particular target groups, such as young children, where the Service should apply additional measures. Its scientists were very heavily involved in international discussions, and linked in with scientists in wider fields and the specialists in spongiform encephalopathy.[13]

18. More widely, the National Blood Service was keeping in close touch with the research and scientific community, and with manufacturers and companies developing new techniques, in order to identify and tackle new risks at the earliest possible stage.[14]

19. The day after the hearing the media drew attention to the risks of cross infection from a donor with Creutzfeldt Jakob Disease to an haemophiliac recipient. The Committee asked the Department why they had not mentioned the case at the hearing. The Department assured us that there had been no intention to withhold information. The case had been in the public domain since December 2000. They explained that the donor had given blood before the Service had switched to using plasma from the United States, and had subsequently developed the disease.[15]

20. The Committee also asked, in the light of a case where a patient had been injected with the wrong medication, what action the Department could take to encourage hospitals to be vigilant in ensuring that they gave patients the right blood. The Department pointed to the Serious Hazards of Transfusion scheme, a confidential voluntary reporting system for major transfusion events in the United Kingdom and the Republic of Ireland, which made sure they identified things as they go wrong. There was also a much closer relationship than before between the National Blood Service and hospitals. The National Blood Service added that it was also following up a recommendation from the Serious Hazards of Transfusion Steering Group, and evaluating computerised identification systems.[16]

21. Where people are infected as a result of transfusions, the Service investigates the reasons and takes steps to stop it happening again. Each case had to be judged on its merits, but where the Service was culpable compensation was paid. For a group of people with haemophilia had been infected with HIV, and compensation of some £2.5 million a year was being paid. In another case, involving people infected with Hepatitis C and where the Service had introduced viral screening as soon as it was available, it had not paid compensation. But in its accounts the Service had provided £1.9 million for possible future payments for clinical negligence, including £1.7 million against the risk of possible payments to the 56 people involved and the associated legal costs.[17]

Conclusions

22. Safety in blood products and their use is paramount. The number of deaths is thankfully very low, but any instances of cross infection or misuse of blood can have very serious consequences for patients, as evidenced by those people infected with HIV and with Hepatitis C. The Department and the National Blood Service should continue to develop their links with the research and scientific community and the manufacturing sector so that they are able to respond quickly to new developments, and minimise the risk of infection.

IMPROVING THE USE OF BLOOD

23. In his report, the Comptroller and Auditor General noted that the National Blood Service had taken action to minimise wastage and loss of blood prior to issue to hospitals, and had improved its performance in 1999-00. The Service had met hospital demand in that year, and when necessary had moved blood strategically to iron out regional shortages. The Service had launched a National Blood Stocks Project aimed at achieving the right balance between locally held stocks and those held by the service. More widely, the Chief Medical Officer had initiated a Better Blood Transfusion initiative, aimed at improving the way hospitals use blood.[18]

24. The National Blood Service confirmed that it was committed to further reduce the wastage of blood, although process losses, leucodepletion and the need to hold stocks in hospitals meant that some losses were inevitable. The Blood Stocks Project had made a contribution to a further reduction in wastage, by bringing the Service and hospitals closer together. The initiative has now been succeeded by the Blood Stocks Management Scheme and the number of hospitals involved has increased to 123. The Better Blood Transfusion initiative had encouraged the development of transfusion committees in hospitals, and the Service had developed its own services through its hospital liaison function and the organisation of its own medical staff. Both initiatives were laying important building blocks in bringing expertise and influence on blood usage in hospitals.[19]

25. The Committee asked about the arrangements for supplying blood and blood products to the private health sector in the United Kingdom, and overseas. The National Blood Service provide blood to the private sector at cost. As a condition of supply, non-NHS Hospitals were required not to make a profit on the material supplied. The Service assured the Committee that there was no evidence that non-NHS hospitals had ever attempted to make profits on blood in breach this long-standing requirement, and that immediate action would be taken if they did.[20] The Service did not supply blood to overseas countries, unless there was an international emergency. However, the Bio Products Laboratory who produce plasma products did export surplus products, under the Income Generation Regulations for the NHS, and used the income for the benefit of the health service.[21]

Conclusions

26. Unless the National Blood Service and hospitals make the best use of blood, there is a risk that there will be less willingness to donate. The Blood Stocks Management Scheme and the Better Blood Transfusion are useful initiatives in helping to minimise wastage, and we look to the National Blood Service to continue its efforts to ensure better management of blood.

27. Only the National Blood Service can take blood from donors, and there is no other source of supply of blood to non-NHS hospitals. Although there is no evidence that non-NHS hospitals have sought to make a profit on blood supplied, the Blood Service needs independent evidence of this. The Service should re-examine the contractual arrangements and consider whether additional assurance, perhaps in the form of audit certificates might improve its confidence, and that of donors, on this point.

IMPROVING THE MANAGEMENT AND OPERATIONS OF THE NATIONAL BLOOD SERVICE

28. In his report, the Comptroller and Auditor General outlined the progress made by the National Blood Service in reorganising the service and restoring confidence after the management and operational problems in the 1990s. He concluded that the Service had improved the efficiency and effectiveness of its operations, but needed to further improve working practices, the use of cost and management information, and the performance measurement framework.[22]

29. We examined in particular:

  • The action taken to restore confidence in the Service;

  • The quality of the Service's risk management and contingency planning;

  • The scope to use costing and other comparisons to improve quality and efficiency.

The action taken to restore confidence in the Service

30. In August 1997, the Secretary of State commissioned a review of clinical concerns raised about proposals by the National Blood Service to transfer processing and testing of blood from Liverpool to Manchester. The Cash report, which also covered concerns in other centres such as Oxford and East Anglia, led to the dismissal of the Service's Chairman and Chief Executive. In announcing this, the Secretary of State drew attention to a serious breakdown of trust between the National Blood Authority and many local people and clinicians in Liverpool. He concluded that the blood transfusion service in Liverpool had been severely damaged, and that there was a widespread loss of confidence in the Authority by clinicians, hospital blood bank medical and laboratory staff, and the general public.[23]

31. The National Blood Service told us that, following the review, it had spent a lot of time in Liverpool and Merseyside working with the staff and local health services. It was following up commitments by the Secretary of State to upgrade the blood centre in Liverpool, with a proposal for a new centre in Speke, and had given a very strong signal that the Service was committed to continuing the service based there. In Oxford, the Service had also been working with local health services, and wanted in particular to develop the research aspects. East Anglia was now operating essentially as a specialist centre offering diagnostic services, had a very strong research base with the local hospital and university and seemed to be moving forward well.[24]

32. In addition, senior staff and the new Chairman now spent a lot of their time out in the Service. The Service had worked very hard to improve staff morale, and by creating a national structure now had the ability to work on standards and to focus expertise on a national basis.[25]

33. The Committee enquired about the terms on which the Chairman and the Chief Executive were dismissed in 1997. The National Blood Service told us that the Chairman had no contract, and was dismissed without compensation. However, under the terms of his contract the Chief Executive received six months pay of £43,000, £65,000 compensation for breach of contract and £124,000 in pension contributions. The Panel taking this decision needed to work within the terms of reference of the Service on disciplinary matters.[26]

The quality of the Service's risk management and contingency planning

34. The Comptroller and Auditor General noted that the National Blood Service takes a strategic approach to handling stocks of blood components. The Service had improved its arrangements for risk management and contingency planning, and these had worked well during the road fuel crisis and in handling a shortage of O negative blood.[27] The Service confirmed that it had put a lot of work into getting contingency plans to a very high standard, and would continue to review them against any new potential threats that might occur.[28]

The scope to use costing and other comparisons to improve quality and efficiency

35. So that the National Blood Service could further improve its efficiency, the Comptroller and Auditor General made a number of recommendations on improving working practices and securing economies.[29] We asked the new Chief Executive of the NHS about the progress made. His first impression was that the Service had come a long way since the crisis of the 1990s, but there was no room for complacency and still a lot of detailed work to be done. He found the Comptroller and Auditor General's report very helpful. He noted that since 1997 the Department had improved the arrangements for monitoring the performance of the Service, including a very formal accountability review, and had improved communication with the Service, for example by the Chief Executive of the Service attending meetings of NHS Chief Executives.[30]

36. The National Blood Service accepted the Comptroller and Auditor General's conclusion that there were opportunities to further improve efficiency. It aimed to secure best practice by adopting a genuinely national structure, and to offer local services within a national framework. The Service was conducting major reviews of all its operational departments and over the next few months would be moving the service towards those best practices. The Service was also taking first steps towards a common set of costings, although it would need a year's experience before it could make meaningful cost comparisons between blood centres.[31]

37. One area where there were still some problems, which made it more difficult to improve services to donors on a consistent basis across the country, was in revised terms and conditions for staff, changes in working practices and multi-skilling. Negotiations were stalled.[32] The Service explained that it was trying to move from 14 semi-autonomous services, each with their own teams, local terms and conditions and working practices. The Service had made progress in introducing multi-skilling in some areas, for example the Midlands and the South-West. Fifty per cent of their mobile teams were now fully multi-skilled , and another 45 per cent were partly multi-skilled. What the Service was trying to achieve in changing the terms and conditions of staff was to protect their earnings, but to pay them on a different basis. It was vital that the Service made progress on working practices that met the needs of donors. It recognised, however, that for some staff the changes sought were far different from their traditional working practices, and the Service had to take the staff with them.[33]

Conclusions

38. The conclusions of the Cash report, and the terms in which the Secretary of State announced the dismissal in 1997 of the Chairman and Chief Executive, were highly critical of the way the Service was managed. While we recognise the need for the Service to operate within the terms of contract and its disciplinary arrangements, we are astonished that the Chief Executive was able to leave with a payoff of £108,000 and a £124,000 contribution to his pension fund. This is not the first case where those responsible for poor management have received significant payoffs. The Department should review the NHS arrangements for taking disciplinary action in such cases.

39. The National Blood Service has taken a number of steps to rebuild confidence following the crisis that developed in the 1990s. Four years on, however, it has still not concluded a deal with staff on new pay, conditions and working practices that will give donors the service they need. The Service should pursue negotiations vigorously.


1  C&AG's Report (HC 6 of Session 2000-2001), paras 1 and 2 Back

2  C&AG's Report (HC 6, Session 2000-2001), paras 1.2, 2.7 and p24 Back

3  ibid, paras 3.6 and 3.13 Figures 17 and 19 Back

4  Evidence, Q8 Back

5  C&AG's Report (HC 6, Session 2000-2001) paras 3.9 and 3.14  Back

6  Evidence, Qs 9-10, 12-14, 27-31, 104-113 Back

7  Evidence, Qs 32-40 Back

8  Evidence, Qs 114-116 Back

9  Evidence, Qs 11, 116-119, 154 Back

10  Evidence, Qs 96-101, 151-153 Back

11  C&AG's Report (HC 6, Session 2000-2001) paras 2, 1.20-1.22, 4.2-4.3 and p30  Back

12  Evidence, Qs 15-17 and Evidence, Appendix 2, pp 19-24 Back

13  Evidence, Qs 85-86, 161-162, 169 Back

14  Evidence, Qs 20-26 Back

15  Evidence, Appendix 2, pp 19-24 Back

16  Evidence, C&AG's Report (HC 6, Session 2000-2001) para 4.3 and Qs 123-126  Back

17  Evidence, Qs 79-84, 91, 195 and Evidence, Appendix 2, pp 19-24 Back

18  C&AG's Report (HC 6, Session 2000-2001) paras 2.7, 2.10, 2.18-2.20, and Evidence, Appendices 1-2, pp 19-24 Back

19  Evidence, Qs 7, 120-122 Back

20  Evidence, Qs 46-48, 88-90, 155-156 and Evidence, Appendix 2, pp 19-24 Back

21  Evidence, Qs 42-45 Back

22  C&AG's Report (HC 6, Session 2000-2001) paras 5-7, 13  Back

23  ibid, para 2 and Appendix 2  Back

24  Evidence, Qs 92-94 Back

25  Evidence, Qs 92-94, 129-132, 166-168 Back

26  Evidence, Qs 57-78, 158-160 Back

27  C&AG's Report (HC 6, Session 2000-2001) paras 2.14, 2.18-2.22  Back

28  Evidence, Qs 134-141 Back

29  C&AG's Report (HC 6, Session 2000-2001) paras 13-14  Back

30  Evidence, Qs 4, 95 Back

31  Evidence, Qs 18-19, 103 Back

32  C&AG's Report (HC 6, Session 2000-2001) paras 5.7-5.8  Back

33  Evidence, Qs 146-150, 164-165 Back


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2001
Prepared 11 July 2001